STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $21.91 billion. The enterprise value is $24.07 billion.
Market Cap | 21.91B |
Enterprise Value | 24.07B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | Feb 20, 2025 |
Share Statistics
STERIS has 98.25 million shares outstanding. The number of shares has decreased by -0.57% in one year.
Current Share Class | 98.25M |
Shares Outstanding | 98.25M |
Shares Change (YoY) | -0.57% |
Shares Change (QoQ) | -0.26% |
Owned by Insiders (%) | 0.29% |
Owned by Institutions (%) | 95.38% |
Float | 97.88M |
Valuation Ratios
The trailing PE ratio is 35.85 and the forward PE ratio is 22.75.
PE Ratio | 35.85 |
Forward PE | 22.75 |
PS Ratio | 4.08 |
Forward PS | 3.81 |
PB Ratio | 3.41 |
P/TBV Ratio | 48.81 |
P/FCF Ratio | 29.16 |
P/OCF Ratio | 19.18 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.94, with an EV/FCF ratio of 32.04.
EV / Earnings | 51.49 |
EV / Sales | 4.46 |
EV / EBITDA | 16.94 |
EV / EBIT | 25.11 |
EV / FCF | 32.04 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.36.
Current Ratio | 2.13 |
Quick Ratio | 1.20 |
Debt / Equity | 0.36 |
Debt / EBITDA | 1.55 |
Debt / FCF | 3.09 |
Interest Coverage | 9.11 |
Financial Efficiency
Return on equity (ROE) is 9.61% and return on invested capital (ROIC) is 6.41%.
Return on Equity (ROE) | 9.61% |
Return on Assets (ROA) | 5.59% |
Return on Invested Capital (ROIC) | 6.41% |
Return on Capital Employed (ROCE) | 10.52% |
Revenue Per Employee | $296,956 |
Profits Per Employee | $25,722 |
Employee Count | 18,179 |
Asset Turnover | 0.50 |
Inventory Turnover | 4.03 |
Taxes
In the past 12 months, STERIS has paid $171.48 million in taxes.
Income Tax | 171.48M |
Effective Tax Rate | 21.72% |
Stock Price Statistics
The stock price has decreased by -1.12% in the last 52 weeks. The beta is 0.92, so STERIS's price volatility has been similar to the market average.
Beta (5Y) | 0.92 |
52-Week Price Change | -1.12% |
50-Day Moving Average | 222.33 |
200-Day Moving Average | 224.11 |
Relative Strength Index (RSI) | 48.45 |
Average Volume (20 Days) | 637,621 |
Short Selling Information
The latest short interest is 1.15 million, so 1.17% of the outstanding shares have been sold short.
Short Interest | 1.15M |
Short Previous Month | 928,683 |
Short % of Shares Out | 1.17% |
Short % of Float | 1.18% |
Short Ratio (days to cover) | 2.04 |
Income Statement
In the last 12 months, STERIS had revenue of $5.40 billion and earned $467.59 million in profits. Earnings per share was $4.72.
Revenue | 5.40B |
Gross Profit | 2.37B |
Operating Income | 958.73M |
Pretax Income | 550.80M |
Net Income | 467.59M |
EBITDA | 1.42B |
EBIT | 958.73M |
Earnings Per Share (EPS) | $4.72 |
Balance Sheet
The company has $155.18 million in cash and $2.32 billion in debt, giving a net cash position of -$2.16 billion or -$22.03 per share.
Cash & Cash Equivalents | 155.18M |
Total Debt | 2.32B |
Net Cash | -2.16B |
Net Cash Per Share | -$22.03 |
Equity (Book Value) | 6.43B |
Book Value Per Share | 65.31 |
Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was $1.14 billion and capital expenditures -$390.70 million, giving a free cash flow of $751.41 million.
Operating Cash Flow | 1.14B |
Capital Expenditures | -390.70M |
Free Cash Flow | 751.41M |
FCF Per Share | $7.65 |
Margins
Gross margin is 43.81%, with operating and profit margins of 17.76% and 8.66%.
Gross Margin | 43.81% |
Operating Margin | 17.76% |
Pretax Margin | 14.62% |
Profit Margin | 8.66% |
EBITDA Margin | 26.33% |
EBIT Margin | 17.76% |
FCF Margin | 13.92% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 1.02%.
Dividend Per Share | $2.28 |
Dividend Yield | 1.02% |
Dividend Growth (YoY) | 9.85% |
Years of Dividend Growth | 10 |
Payout Ratio | 48.32% |
Buyback Yield | 0.57% |
Shareholder Yield | 1.59% |
Earnings Yield | 2.13% |
FCF Yield | 3.43% |
Analyst Forecast
The average price target for STERIS is $260.00, which is 16.59% higher than the current price. The consensus rating is "Buy".
Price Target | $260.00 |
Price Target Difference | 16.59% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 6.47% |
EPS Growth Forecast (5Y) | 24.29% |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
Last Split Date | Aug 25, 1998 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.02 and a Piotroski F-Score of 7.
Altman Z-Score | 5.02 |
Piotroski F-Score | 7 |